Bio-Rad Laboratories, Inc. Stock NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
16:10:00 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 365.08 USD | +8.33% |
|
+8.33% | +17.50% |
| 08-07 | RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating | MT |
| 08-05 | RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating | MT |
| Market Cap | 10.12B 8.67B 8.11B 7.42B 14.01B 966B 14.13B 95.68B 37.28B 487B 38.01B 37.18B 1,612B | P/E 2026 * |
45.8x | P/E 2027 * | 44.9x |
|---|---|---|---|---|---|
| Enterprise Value | 9.37B 8.03B 7.51B 6.87B 12.97B 894B 13.09B 88.6B 34.52B 451B 35.2B 34.43B 1,492B | EV / Sales 2026 * |
3.64x | EV / Sales 2027 * | 3.48x |
| Free-Float |
60.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +8.33% | ||
| 1 week | +8.33% | ||
| Current month | +18.01% | ||
| 1 month | +18.01% | ||
| 3 months | +36.51% | ||
| 6 months | +35.78% | ||
| Current year | +17.50% |
| 1 week | 365.08 |  | 365.08 |
| 1 month | 337 | | 365.08 |
| Current year | 244.54 | | 365.08 |
| 1 year | 244.54 | | 365.08 |
| 3 years | 0 | | 373.78 |
| 5 years | 0 | | 818.6 |
| 10 years | 0 | | 818.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 2002-12-31 |
| President | 61 | 2024-09-08 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 2024-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 2011-12-31 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 2017-04-24 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 2017-04-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.33% | +8.33% | - | - | 10.12B | |
| -0.46% | +5.22% | -12.41% | +11.93% | 202B | |
| -1.89% | +0.60% | -1.69% | +12.44% | 119B | |
| +1.33% | +4.97% | +12.12% | +83.51% | 61.78B | |
| +0.40% | -5.32% | +30.83% | +55.98% | 52.35B | |
| -0.50% | +4.22% | -4.95% | -31.49% | 51.96B | |
| -2.09% | +0.45% | +8.39% | -11.71% | 34.36B | |
| +2.71% | +2.18% | - | - | 30.44B | |
| -1.37% | +0.54% | +40.60% | -11.04% | 24.87B | |
| +0.04% | -0.90% | -5.19% | +24.89% | 24.07B | |
| Average | +0.65% | +1.45% | +8.46% | +16.81% | 66.74B | |
| Weighted average by Cap. | -0.29% | +2.83% | +1.00% | +18.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.2B 2.06B 1.89B 3.56B 245B 3.59B 24.32B 9.48B 124B 9.66B 9.45B 410B | 2.63B 2.26B 2.11B 1.93B 3.64B 251B 3.68B 24.89B 9.7B 127B 9.89B 9.67B 419B |
| Net income | 225M 193M 180M 165M 311M 21.47B 314M 2.13B 829M 10.81B 845M 826M 35.82B | 230M 197M 184M 169M 318M 21.94B 321M 2.17B 847M 11.05B 864M 845M 36.62B |
| Net Debt | -749M -642M -600M -549M -1.04B -71.46B -1.05B -7.08B -2.76B -36B -2.81B -2.75B -119B | -965M -827M -774M -707M -1.34B -92.1B -1.35B -9.12B -3.56B -46.4B -3.62B -3.55B -154B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
Select your edition
All financial news and data tailored to specific country editions
